Elsevier

Brain and Development

Volume 15, Issue 1, January–February 1993, Pages 1-22
Brain and Development

The expanding clinical spectrum of mitochondrial diseases

https://doi.org/10.1016/0387-7604(93)90002-PGet rights and content

Abstract

The mitochondrion is the only extranuclear organelle containing DNA (mtDNA). As such, genetically determined mitochondrial diseases may result from a molecular defect involving the mitochondrial or the nuclear genome. The first is characterized by maternal inheritance and the second by Mendelian inheritance. Ragged-red fibers (RRF) are commonly seen with primary lesions of mtDNA, but this association is not invariant. Conversely, RRF are seldom associated with primary lesions of nuclear DNA. Large-scale rearrangements (deletions and insertions) and point mutations of mtDNA are commonly associated with RRF and lactic acidosis, e.g. Kearns-Sayre syndrome (KSS) (major large-scale rearrangements), Pearson syndrome (large-scale rearrangements), myoclonus epilepsy with RRF (MERRF) (point mutation affecting tRNAlys gene), mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) (two point mutations affecting tRNAleu(UUR) gene) and a maternally-inherited myopathy with cardiac involvement (MIMyCa) (point mutation affecting tRNAleu(UUR) gene). However, RRF and lactic acidosis are absent in Leber hereditary optic neuropathy (LHON) (one point mutation affecting ND4 gene, two point mutations affecting ND1 gene, and one point mutation affecting the apocytochromeb subunit of complex III), and the condition associated with maternally inherited sensory neuropathy (N), ataxia (A), retinitis pigmentosa (RP), developmental delay, dementia, seizures, and limb weakness (NARP) (point mutation affecting ATPase subunit 6 gene). The point mutations in MELAS, MIMyCa, and MERRF, and the large-scale mtDNA rearrangements in KSS and Pearson syndrome have a broader biochemical impact since these molecular defects involve the translational sequence of mitochondrial protein synthesis. The nuclear defects involving mitochondrial function generally are not associated with RRF. The biochemical classification of mitochondrial diseases principally catalogues these nuclear defects. This classification divides mitochondrial diseases into five categories. Primary and secondary deficiencies of carnitine are examples of a substrate transport defect. A lipid storage myopathy is often present. Disturbances of pyruvate or fatty acid metabolism are examples of substrate utilization defects. Only four defects of the Krebs cycle are known: fumarase deficiency, dihydrolipoyl dehydrogenase deficiency, α-ketoglutarate dehydrogenase deficiency, and combined defects of muscle succinate dehydrogenase and aconitase. Luft disease is the singular example of a defect in oxidation-phosphorylation coupling. Defects of respiratory chain function are manifold. Two clinical syndromes predominate, one involving limb weakness, and the other primarily affecting brain function. Leigh syndrome may result from different enzyme defects, most notably pyruvate dehydrogenase complex deficiency, cytochromec oxidase deficiency, complex I deficiency, and complex V deficiency associated with the recently described NARP point mutation. A new group of mitochondrial diseases has emerged. These conditions result from defective interaction between the nuclear and mitochondrial genomes. The first example is an autosomal dominant condition associated with multiple mtDNA deletions. The second example is a fatal infantile disorder associated with reduced abundance of mtDNA, termed the mitochondrial DNA depletion syndrome.

References (140)

  • KotagalS et al.

    Impaired NADH-CoQ reductase activity in a child with moya-moya syndrome

    Pediatr Neurol

    (1988)
  • Van CosterR et al.

    Cytochromec oxidase-associated Leigh syndrome: phenotypic features and pathogenetic speculations

    J Neurol Sci

    (1991)
  • ErnsterL et al.

    Mitochondria: a historical review

    J Cell Biol

    (1981)
  • NassS et al.

    Intramitochondrial fibers with DNA characteristics

    J Cell Biol

    (1963)
  • GilesR.E. et al.

    Maternal inheritance of human mitochondrial DNA

  • AndersonS et al.

    Sequence and organization of the human mitochondrial genome

    Nature

    (1981)
  • ZevianiM. et al.

    Defects of mitochondrial DNA

    Br Pathol

    (1992)
  • EngelW.K. et al.

    Rapid examination of muscle tissue: an improved trichrome stain method for fresh-frozen biopsy sections

    Neurology

    (1963)
  • Morgan-HughesJ.A.

    The mitochondrial myopathies

  • DiMauroS. et al.

    Mitochondrial myopathies

    J Inher Metab Dis

    (1987)
  • ShoffnerJ.M. et al.

    Oxidative phosphorylation diseases: disorders of two genomes

  • SchatzG.

    The mitochondrial protein import machinery

  • LedleyF.D. et al.

    Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes mutO methylmalonic acidemia

  • PurdueP.E. et al.

    Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type I

    J Cell Biol

    (1990)
  • OwenO.E. et al.

    Brain metabolism during fasting

    J Clin Invest

    (1967)
  • De VivoD.C.

    The effects of ketone bodies on glucose utilization?

  • ReichmannH. et al.

    Enzymes of fatty acid β-oxidation in developing brain

    J Neurochem

    (1988)
  • DiMauroS et al.

    Muscle carnitine palmityltransferase deficiency and myoglobinuria

    Science

    (1973)
  • EngelA.G. et al.

    Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome

    Science

    (1973)
  • TeinI. et al.

    Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy

    Pediatr Res

    (1990)
  • StanleyC.A. et al.

    Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake

    Ann Neurol

    (1991)
  • Falik-BorensteinZ.C. et al.

    Brief report: renal tubular acidosis in carnitine palmitoyl transferase type I deficiency

    N Engl J Med

    (1992)
  • DemaugreF. et al.

    Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities

    Pediatr Res

    (1988)
  • StanleyC.A. et al.

    Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane

    N Engl J Med

    (1992)
  • StanleyC.A. et al.

    Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels

    Pediatr Res

    (1983)
  • TreemW.R. et al.

    Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-terml-carnitine supplementation

    J Inher Metab Dis

    (1989)
  • HaleD.E. et al.

    Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels

    Pediatr Res

    (1985)
  • AmendtB.A. et al.

    Short-chain acyl-coenzyme A dehydrogenase deficiency: clinical and biochemical studies in two patients

    J Clin Invest

    (1987)
  • TurnbullD.M. et al.

    Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency

    N Engl J Med

    (1984)
  • CoatesP.M. et al.

    Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness

    J Clin Invest

    (1988)
  • RinaldoP. et al.

    Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines

    Pediatr Res

    (1991)
  • BellR.B. et al.

    Electron transfer flavoprotein: ubiquinone oxidoreductase (ETF:QO) deficiency in an adult

    Neurology

    (1990)
  • TeinI. et al.

    Short-chainl-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy

    Ann Neurol

    (1991)
  • RocchiccioliF. et al.

    Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood

    Pediatr Res

    (1990)
  • Dionisi-ViciC. et al.

    Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

    J Pediatr

    (1991)
  • Van CosterR.N. et al.

    Pyruvate car☐ylase deficiency: a benign variant with normal development

    Pediatr Res

    (1991)
  • SaudubrayJ.M. et al.

    Neonatal congenital lactic acidosis with pyruvate car☐ylase deficiency in two siblings

    Acta Paediatr Scand

    (1976)
  • RobinsonB.H. et al.

    The molecular basis for the two different clinical presentations of classical pyruvate car☐ylase deficiency

    Am J Hum Genet

    (1984)
  • AtkinB.M. et al.

    Pyruvate car☐ylase and phosphoenolpyruvate car☐ykinase activity in leukocytes and fibroblasts from a patient with pyruvate car☐ylase deficiency

    Pediatr Res

    (1979)
  • HommesF.A. et al.

    Leigh's encephalomyopathy: an inborn error of gluconeogenesis

    Arch Dis Child

    (1968)
  • Cited by (152)

    • Diagnosis of primary mitochondrial disorders -Emphasis on myopathological aspects

      2021, Mitochondrion
      Citation Excerpt :

      The occurrence of RRFs and COX negative fibers vary in biopsies depending on the genotype. Frequencies of RRFs and COX negative fibers is lesser in MELAS and MERRF due to mtDNA point mutations than in CPEO due to mtDNA deletion, and are usually absent in LHON due to mtDNA point mutations (De Vivo 1993, Tarnopolsky et al., 2004, Choi et al, 2010). COX negative fibers have been noted to occur more frequently than RRFs in CPEO patients associated with mtDNA point mutations and single deletions, and multiple mtDNA deletions due to POLG1 mutations (Zierz et al., 2015, Deepha et al., 2021).

    • Genetic heterogeneity of mitochondrial genome in thiamine deficient Leigh syndrome patients

      2019, Journal of the Neurological Sciences
      Citation Excerpt :

      Neither the RRF nor any specific enzyme deficiency was identified in the biopsy samples of these patients. However, relative paucity or absence of RRFs is known to be common in muscle biopsies of patients with mitochondrial cytopathiessuch as LHON, neuropathy ataxia and retinitis pigmentosa (NARP) [36–39]. Similarly, NADH-dehydrogenase stain rarely shows a pattern of decreased activity to suggest the underlying defect, as it has been reported in several cases with severe complex I defect [38,40].

    • Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments

      2019, Mitochondrion
      Citation Excerpt :

      The m.8993T>G/C mutation is associated with complex V deficiency too (De Meirleir et al., 2004). In fact, the disease has been associated with the etiologies of NARP and LS (De Vivo, 1993; National Organization for Rare Disorders, 2016; Rat Genome Database, 2017). Complex V deficiency is a very rare metabolic disorder, which is also caused by other mutations in the ATP6 and ATP8 genes (Auré et al., 2013; Kytövuori et al., 2016), such as m.8561C>G (in the overlap region of ATP6 and ATP8) (Kytövuori et al., 2016), m.8969G>A (in ATP6) (Burrage et al., 2014) and m.8529G>A (in ATP8) (Jonckheere et al., 2008) (Fig. 1).

    • Organic Acids

      2018, Volpe's Neurology of the Newborn
    • Degenerative Disorders of the Newborn

      2018, Volpe's Neurology of the Newborn
    • Hypotonia and Weakness: Level of the Muscle

      2018, Volpe's Neurology of the Newborn
    View all citing articles on Scopus

    This paper was presented as an invited lecture at the 34th annual meeting of the Japanese Society of Child Neurology, Ohmiya, June 11–13, 1992.

    View full text